Latest enterprise software release expands functionalities for comprehensive characterization and quality monitoring of biopharmaceuticals Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of Genedata Expressionist® 16.5, the latest version of its platform for streamlining and automating mass spectrometry data workflows, from early discovery to late-stage […]

Pierian®, a global leader in advanced clinical genomics technology and services, is pleased to announce an exciting partnership with P4 Diagnostix®, a leading-edge network of nationally recognized laboratories. Now physician-owned laboratories (POLs) that specialize in urology, gastroenterology, or women’s health, can add next-generation sequencing (NGS) testing for hereditary cancer to their routine diagnostic practice. Lowering the […]

– Qlucore’s software is used in leading research projects Swedish Qlucore – a leader in precision diagnostics for the analysis of cancer – has played an important role in the Swedish-Danish collaboration iCOPE, which aims, among other things, to improve the treatment of children affected by acute leukemia. With diagnoses increasing by 6-10 percent a […]

Global Biopharma leader drives digital innovation and AI-based biopharma R&D by expanding footprint of Genedata Biopharma Platform Basel, Switzerland—Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Sanofi has expanded the use of Genedata Biologics® to new sites, groups, and application areas, including high-throughput engineering of next-generation multi-specific antibody therapeutics. “We chose Genedata Biologics to support our quickly […]

P4 Enhances their NGS capabilities to offer Precision Medicine to their patients INDIANAPOLIS — P4 Diagnostix®, a network of nationally recognized laboratories (“P4”), will be partnering with Pierian, a global leader in advanced clinical genomics technology and services, to launch somatic testing for prostate cancer patients. Using the Illumina TruSight Oncology 500 cancer panel, P4 and […]

RIYADH, Kingdom of Saudi Arabia — King Faisal Specialist Hospital and Research Centre (KFSH&RC) will integrate Saphetor’s proprietary human genome variant interpretation engine, VarSome, into its research and clinical genomics programs. The integration aligns with Saudi Arabia’s Vision 2030 to strengthen the Kingdom’s healthcare sector and its services with technological advancements. KFSH&RC is a leading […]

Newly Created Form Bio Raises $30M Series A Funding Led by JAZZ Venture Partners to empower life scientists with a complete platform for managing large datasets, executing verified workflows, visualizing results and collaborating with their peers – bridging the gap between data and discovery. DALLAS, TX – Colossal Biosciences, the de-extinction company behind the woolly mammoth and […]

– New function provides better information for data analysis and cancer diagnostics Nasdaq First North-listed Qlucore, whose software creates the conditions for faster, more precise, better cancer diagnostics and helps researchers with data analysis, has received a patent in Europe. This is for a new feature which generates robust analysis answers, even in the presence […]

VALENCIA, Spain — BioBam announced last week the release of OmicsBox 2.2. This new version of BioBam’s bioinformatics solution offers new Single Cell and Long Read Data Analysis Features among other platform improvements. These new additions allow the researchers to use the latest sequencing technologies for their genomics and transcriptomics studies. Dr. Stefan Götz, CEO said: “I am very excited about this […]

Highlights include: a memorandum of understanding with Memorial Sloan Kettering Cancer Center and a novel new partnership with Boundless Bio, a next-generation precision oncology company SOPHiA GENETICS’ next-generation solution CarePath, fueled by current real world observational data, was previewed for attendees BOSTON and GENEVA, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in […]